EpiTherapeutics
EpiTherapeutics is a biopharmaceutical firm that develops cancer drugs based on the research in epigenetics field.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed EpiTherapeutics Information
EpiTherapeutics was acquired by
Gilead Sciences.
The acquisition happend on 2015-05-06.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Ole Maaløesvej 3
City: København N
State: south denmark
Zip: 2200
Country: DK
Financial Info
Stage:
undisclosed
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
EpiTherapeutics is a biopharmaceutical firm that develops cancer drugs based on the research in epigenetics field.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2008 | Funding Round | 2 | - |
Novo Holdings Seed Capital Novo Holdings Seed Capital |
12/2008 | Funding Round | 2 | - |
Novo Holdings Seed Capital Novo Holdings Seed Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
